| Absolute and relative reflectivity | 283 |
| Acute macular neuroretinopathy | 123, 193 |
| Age-related macular degeneration | 6 |
| Agreement | 264 |
| Albinism | 321 |
| Alcohol-assisted photorefractive keratectomy | 127 |
| Amblyopia | 317 |
| Anemia | 381 |
| Angiography | 264 |
| Anterior chamber | 20 |
| Anti-vascular endothelial growth factor | 110, 275 |
| Anti-VEGF treatment | 163 |
| Artificial intelligence | 37, 392, 393 |
| Asphericity | 127 |
| Attention-deficit and hyperactivity disorder | 15 |
| Autofluorescence | 6 |
| Autosomal recessive inheritance | 245 |
| BAC | 75 |
| Bacterial keratitis | 258 |
| Bartonella henselae neuroretinitis | 371 |
| Behçet’s uveitis | 169 |
| Bevacizumab | 187 |
| Bilateral disc swelling | 371 |
| Biologics | 169 |
| Birth weight | 351 |
| Blepharoplasty | 151 |
| Blindness | 288 |
| Body position | 271 |
| BRAF | 50 |
| Brinzolamide | 44 |
| Cataract | 94, 133, 288 |
| Cataract surgery | 390 |
| Child | 271 |
| Chorioretinitis | 248 |
| Choroidal thickness | 221 |
| Chrysomya bezziana | 381 |
| Class 3 variant of uncertain significance | |
| (c755A>G [P.Lys252Arg]) | 245 |
| Coherence | 264 |
| Collagen cross-linking | 200 |
| Colon cancer | 377 |
| Complete blood count | 87 |
| Congenital cataract | 245 |
| Conjunctiva | 53 |
| Conjunctival melanoma | 293, 362 |
| Consanguineous marriage | 252 |
| Contact lenses | 234 |
| Contrast sensitivity | 151 |
| Cornea | 20, 71 |
| Corneal edema | 115 |
| Corneal topography | 20 |
| Craniopharyngioma | 317 |
| Cyclopentolate | 20 |
| Cystoid macular edema | 252 |
| Cytomegalovirus | 304 |
| Deep learning | 37 |
| Dermatochalasis | 151 |
| Dexamethasone implant | 115 |
| Diabetic macular edema | 163 |
| Diagnosis | 293 |
| Dry eye disease | 133, 390 |
| Ellipsoid zone reflectivity | 283 |
| Epiretinal membrane | 53 |
| Esotropia | 143 |
| Estrogen receptor | 216 |
| Eye | 53 |
| Eyelash ptosis | 356 |
| Eyelid laxity | 356 |
| Floppy eyelid | 356 |
| Fortified antibiotics | 258 |
| Fovea plana | 190 |
| Foveal avascular zone | 228 |
| Foveal hypoplasia | 321 |
| Fungal keratitis | 107 |
| Fungi | 332 |
| Fusarium | 332 |
| Fusional vergence | 15 |
| Ganglion cell complex | 26 |
| Ganglion cell layer | 211 |
| Gene | 216 |
| Genetics | 143 |
| Gestational age | 351 |
| Glaucoma | 26, 264 |
| GQL-15 | 75 |
| Graft rejection | 304 |
| Graft survival | 323 |
| Granular corneal dystrophy type 1 | 64 |
| Graves’ ophthalmopathy | 221 |
| Green disease | 99 |
| Hemianopsia | 317 |
| High order aberration | 151 |
| Higher-order aberration | 127 |
| Hybrid lenses | 234 |
| Imaging | 169 |
| In vivo confocal microscopy | 107, 183 |
| Indocyanine green angiography | 248 |
| Infectious keratitis | 323 |
| Inferior oblique muscle overaction | 82 |
| Inheritance | 143 |
| Intracameral bevacizumab | 110 |
| Intraocular inflammation | 110 |
| Intraocular pressure | 211, 271 |
| Inverse retinitis pigmentosa | 110 |
| Iodine | 255 |
| Iris pigment epithelial cyst | 31 |
| Iris stromal cyst | 31 |
| Ischemia | 123 |
| Joint hypermobility | 71 |
| Keratitis | 107, 206, 332 |
| Keratoconus | 20, 200, 234, 339 |
| Keratometry | 151 |
| LASIK | 211 |
| Leber’s hereditary optic neuropathy | 313 |
| Lymphoma | 53 |
| Machine learning | 37, 392, 393 |
| Macular atrophy | 252 |
| Macular cystoid lesion | 44 |
| Macular hole | 283 |
| Malignancy | 377 |
| Management | 362 |
| Marginal zone | 53 |
| Medical ethics | 37, 392, 393 |
| Melanoma | 50 |
| Microbial keratitis | 206 |
| Mini-scleral lens | 339 |
| Morquio syndrome | 183 |
| Mucopolysaccharidoses | 183 |
| Multimodal imaging | 190 |
| Myopia | 387 |
| Neovascular age-related macular degeneration | 275 |
| Neovascular glaucoma | 110 |
| Nidek RS-3000 Advance | 228 |
| Obstructive sleep apnea syndrome | 356 |
| OCT | 211 |
| OCT anatomic variations | 99 |
| OCT artifacts | 99 |
| Ocular adnexal lymphoma | 53 |
| Ocular disease | 216 |
| Ocular response analyzer | 71 |
| Ocular Surface Disease Index | 133 |
| Ocular tonometry | 271 |
| Ophthalmia nodosa | 107 |
| Ophthalmology | 37, 392, 393 |
| Ophthalmomyiasis | 381 |
| Optic coherence tomography | 228 |
| Optic disc hypoplasia | 190 |
| Optical | 264 |
| Optical coherence tomography | 1, 26, 99, 123, 163, |
| 193, 221, 252, 313, 321 | |
| Optical coherence tomography angiography | 123, 248, |
| 313, 321 | |
| Orbital myiasis | 381 |
| OSDI | 75 |
| Paracentral acute middle maculopathy | 193 |
| Paraneoplastic syndrome | 377 |
| Pars plana vitrectomy | 115 |
| Penetrating keratoplasty | 206, 304 |
| Penetrating keratoplasty | 323 |
| Periorbital tissue | 356 |
| Peripheral abnormalities | 6 |
| Phacoemulsification | 115, 133,308 |
| Piggyback lenses | 234 |
| Pine processionary caterpillar | 107 |
| Platelet | 351 |
| POEMS syndrome | 371 |
| Polymorphism | 216 |
| Posterior capsular opacification | 1 |
| Posterior microphthalmos | 44 |
| Posterior vitreous detachment | 53 |
| Primary open-angle glaucoma | 75 |
| PRK | 127 |
| Prognosis | 169, 293, 221 |
| Prognosis | 362 |
| Pseudoptosis | 151 |
| Purtscher retinopathy | 123 |
| R555W mutation | 64 |
| Radiation retinopathy | 156 |
| Red disease | 99 |
| Retina | 228 |
| Retinal atrophy | 387 |
| Retinal nerve fiber | 211 |
| Retinal nerve fiber layer | 313 |
| Retinopathy | 255 |
| Retinopathy of prematurity | 87, 351 |
| Retinoschisis | 44 |
| Rhegmatogenous retinal detachment | 94 |
| Rigid gas-permeable lenses | 234 |
| Risk factors | 351 |
| Risk prediction | 87 |
| Sarcoidosis | 50 |
| Scheie syndrome | 183 |
| Schirmer’s test | 133 |
| Scleral lenses | 234 |
| Scleritis | 377 |
| Seasonal | 94 |
| Signal strength | 1 |
| Situs inversus of the optic disc | 190 |
| Soft lenses | 234 |
| Somalia | 288 |
| Spectral Domain optical coherence tomography | 53 |
| SS-OCT | 31 |
| SS-OCTA | 31 |
| Standard Dresden protocol | 200 |
| Stereoacuity | 15 |
| Stereotactic radiosurgery | 156 |
| Stickler syndrome | 387 |
| Strabismus | 143 |
| Surgery | 94 |
| Surgical results | 82 |
| TGFBI gene | 64 |
| Tilted optic disc | 190 |
| Topical treatment | 258 |
| Toxic | 255 |
| Toxoplasmosis | 248 |
| Transepithelial photorefractive keratectomy | 127 |
| Trauma | 288 |
| Travoprost | 75 |
| Treatment | 169 |
| Treatment response | 275 |
| Trypan blue | 308 |
| Type II neovascularization | 187 |
| UBM | 31 |
| Ultrawide-field imaging | 6 |
| Unilateral retinal pigment epithelium dysgenesis | 187 |
| Uveal melanoma | 156 |
| Uveitis | 50 |
| Vemurafenib | 50 |
| Vessel density | 228 |
| Viral endotheliitis | 304 |
| Visual acuity | 1 |
| Visual performance | 339 |
| Vitrectomy | 283 |
| Vitreou | 308 |
| White dot syndrome | 248 |
| World Health Organization | 288 |
| X-linked retinoschisis | 252 |
| Z-myotomy | 82 |